Efficacy of aflibercept for the treatment of chronic non-ischemic CRVO-associated macular edema after treatment with other anti-VEGF agents
Publication
, Journal Article
Todorich, B; Lin, P; Shieh, C; Fekrat, S
Published in: Journal of Eye and Ophthalmology
2014
Duke Scholars
Published In
Journal of Eye and Ophthalmology
DOI
EISSN
2055-2408
Publication Date
2014
Volume
1
Issue
1
Start / End Page
3 / 3
Publisher
Herbert Publications PVT LTD
Citation
APA
Chicago
ICMJE
MLA
NLM
Todorich, B., Lin, P., Shieh, C., & Fekrat, S. (2014). Efficacy of aflibercept for the treatment of chronic non-ischemic CRVO-associated macular edema after treatment with other anti-VEGF agents. Journal of Eye and Ophthalmology, 1(1), 3–3. https://doi.org/10.7243/2055-2408-1-3
Todorich, Bozho, Phoebe Lin, Christine Shieh, and Sharon Fekrat. “Efficacy of aflibercept for the treatment of chronic non-ischemic CRVO-associated macular edema after treatment with other anti-VEGF agents.” Journal of Eye and Ophthalmology 1, no. 1 (2014): 3–3. https://doi.org/10.7243/2055-2408-1-3.
Todorich B, Lin P, Shieh C, Fekrat S. Efficacy of aflibercept for the treatment of chronic non-ischemic CRVO-associated macular edema after treatment with other anti-VEGF agents. Journal of Eye and Ophthalmology. 2014;1(1):3–3.
Todorich, Bozho, et al. “Efficacy of aflibercept for the treatment of chronic non-ischemic CRVO-associated macular edema after treatment with other anti-VEGF agents.” Journal of Eye and Ophthalmology, vol. 1, no. 1, Herbert Publications PVT LTD, 2014, pp. 3–3. Crossref, doi:10.7243/2055-2408-1-3.
Todorich B, Lin P, Shieh C, Fekrat S. Efficacy of aflibercept for the treatment of chronic non-ischemic CRVO-associated macular edema after treatment with other anti-VEGF agents. Journal of Eye and Ophthalmology. Herbert Publications PVT LTD; 2014;1(1):3–3.
Published In
Journal of Eye and Ophthalmology
DOI
EISSN
2055-2408
Publication Date
2014
Volume
1
Issue
1
Start / End Page
3 / 3
Publisher
Herbert Publications PVT LTD